Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Oct 5 - Oct 10
After 68 weeks, the semaglutide group lost about 13.7 percent of body weight, compared with 3.2 percent on placebo
doi: 10.5281/zenodo.14634757
Choosing the right medication is a collaborative process
Step 1: Membership & Intake Signing up is easy
In November 2024, Amgen unwrapped Phase 2 data for MariTide, touting an up to 20% reduction in body weight at 52 weeks, an effect that fell on the lower end of what investors had been expecting
US$ 27.46
.webp)
US$ 28.03
US$ 23.50
